Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Here are some of today’s key research highlights, with a focus on enhancing survivors’ health.
Read highlighted cancer research that will be presented at the 2017 ASCO Annual Meeting, where oncology professionals from around the globe will gather in Chicago in June.
The Multidisciplinary Thoracic Cancers Symposium brings oncology professionals together to discuss ways to best treat people with lung cancer and other thoracic cancers. Dr. Nathan Pennell describes some of the research presented on targeted therapy, radiation therapy, and health disparities.
At the 2017 Clinical Immuno-Oncology Symposium, new research will be presented on the link between gut bacteria and immunotherapy for melanoma and the impact of tumor location in predicting survival from colorectal cancer.
At the 2017 Gastrointestinal Cancers Symposium, new research will be presented that may help improve the treatment of metastatic colorectal cancer, esophageal cancer, and rectal cancer.
The Importance of Palliative Care for Patients and Caregivers: News from the 2016 Palliative Care in Oncology Symposium
Research presented this weekend will highlight the importance of access to palliative care that addresses the health and well-being of patients and caregivers.
At the 2016 ASCO Annual Meeting, Vice President Joe Biden talked about the Moonshot Initiative and what the future of cancer research offers.
Oncology professionals from around the world are in Chicago for the ASCO Annual Meeting. There, they will discuss the latest advances and newest thoughts in cancer research. Some of those advances focus on improving the quality of care and patients’ access to it.
Oncology professionals from around the world are in Chicago for the ASCO Annual Meeting. There, they will discuss the latest advances and newest thoughts in cancer research. Today’s highlights cover research that could potentially have the greatest impact to patient care for breast cancer, glioblastoma, neuroblastoma, and multiple myeloma.
These studies from the ASCO Annual Meeting show some of the newest thoughts and latest advances in using immunotherapy and targeted therapy to treat bladder, stomach, and lung cancers.